In the last trading session, 1.16 million Septerna Inc (NASDAQ:SEPN) shares changed hands as the company’s beta touched 0. With the company’s per share price at $5.80 changed hands at -$0.09 or -1.53% during last session, the market valuation stood at $257.54M. SEPN’s last price was a discount, traded about -399.83% off its 52-week high of $28.99. The share price had its 52-week low at $4.17, which suggests the last value was 28.1% up since then.

Septerna Inc (NASDAQ:SEPN) trade information

Instantly SEPN was in red as seen at the end of in last trading. With action -49.78%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -74.67%, with the 5-day performance at -49.78% in the red. However, in the 30-day time frame, Septerna Inc (NASDAQ:SEPN) is -70.07% down.

The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 58.57% from its current market value. According to analyst projections, SEPN’s forecast low is 14 with 14 as the target high. To hit the forecast high, the stock’s price needs a -141.38% plunge from its current level, while the stock would need to soar -141.38% for it to hit the projected low.

Septerna Inc (SEPN) estimates and forecasts

Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 150k. 3 analysts are of the opinion that Septerna Inc’s revenue for the current quarter will be 133.33k.

Septerna Inc (NASDAQ:SEPN)’s Major holders

Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Select Portfolios – Health Care and Fidelity Select Portfolios – Biotechnology. With 213.0 shares estimated at $1.24 million under it, the former controlled 0.48% of total outstanding shares. On the other hand, Fidelity Select Portfolios – Biotechnology held about 0.32% of the shares, roughly 140.2 shares worth around $0.81 million.